This is a non-core endpoint: only basic statistics are computed.
Benign neoplasm: Nasopharynx
CD2_BENIGN_NASOPHARYNX_EXALLC
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
|
1. Apply sex-specific ruleNone |
- |
2. Check conditionsNone |
|
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
- |
4. Check minimum number of eventsNone |
- |
5. Include endpointsNone |
- |
6. Filter based on genotype QC (FinnGen only)None |
- |
Control definitions (FinnGen only)
- Control exclude
- C3_CANCER, C3_CANCER_WIDE
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- D10
- Name in latin
- Neoplasma benignum nasopharyngis
Similar endpoints
↥List of similar endpoints to
Benign neoplasm: Nasopharynx
based on the number of shared cases.
Similar with more cases:
- Benign neoplasm: Nasopharynx
- Benign neoplasm of mouth and pharynx
- Benign neoplasm of mouth and pharynx
- Benign neoplasms
- Benign neoplasms
Similar with less cases:
Case counts by codes
↥FinnGen case counts by registry codes:
No upset plot: script not run.
No upset table: script not run.
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 312 | 155 | 157 |
| Unadjusted period prevalence (%) | 0.06 | 0.05 | 0.07 |
| Median age at first event (years) | 56.74 | 54.98 | 58.49 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 270
- Matched controls
- 2699
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
D10.6
ICD-10 Finland
Benign neoplasm: Nasopharynx
+∞
320.7
240
*
EMA30
NOMESCO Finland
Biopsy of rhinopharynx
+∞
64.2
59
*
UDH02
NOMESCO Finland
Rhinopharyngoscopy
13.3
47.6
89
96
EMB30
NOMESCO Finland
Adenotomy
26.7
24.1
33
14
130
Kela drug reimbursment
Malignant tumour
+∞
21.1
20
*
WF002
NOMESCO Finland
Radical radiotherapy
+∞
17.9
17
*
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
+∞
16.8
16
*
21070
ICD-8 Finland
Benign neoplasm of buccal cavity and pharynx, Nasopharynx
+∞
16.8
16
*
UDQ12
NOMESCO Finland
Flexible laryngoscopy
7.6
16.8
40
60
J35.2
ICD-10 Finland
Hypertrophy of adenoids
20.8
15.8
23
12
2107A
ICD-9 Finland
Benign neoplasm of lip, oral cavity and pharynx, Nasopharynx
+∞
15.8
15
*
H02AB02
ATC
dexamethasone; systemic
47.9
15.3
18
*
DHA10
NOMESCO Finland
Biopsy of cavity of nose
26.8
14.9
20
8
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
+∞
14.7
14
*
DCA20
NOMESCO Finland
Insertion of ventilating tube through tympanic membrane
13.0
13.9
24
20
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
27.4
13.5
18
7
ENA10
NOMESCO Finland
Biopsy of pharynx
73.4
12.7
14
*
D14.0
ICD-10 Finland
Benign neoplasm: Middle ear, nasal cavity and accessory sinuses
21.3
12.6
18
9
H65.2
ICD-10 Finland
Chronic serous otitis media
21.3
12.6
18
9
A03FA01
ATC
metoclopramide; systemic, rectal
3.8
12.1
54
165
WX408
NOMESCO Finland
General anesthesy, balanced
2.8
11.7
91
416
8090/3-C44.9
ICD-O-3
Basal cell carcinoma, NOS, of skin, NOS
+∞
11.5
11
*
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
+∞
11.5
11
*
UDC00
NOMESCO Finland
Ear microscopy
4.8
10.9
37
87
DCA10
NOMESCO Finland
Paracentesis of tympanic membrane
15.0
10.6
17
12
C61
ICD-10 Finland
Malignant neoplasm of prostate
114.3
10.5
11
*
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
+∞
10.5
10
*
PJA12
NOMESCO Finland
Sentinel node biopsy
+∞
10.5
10
*
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
+∞
10.5
10
*
8140/3-C61.9
ICD-O-3
Adenocarcinoma, NOS, of prostate gland
+∞
10.5
10
*
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
2.6
10.2
87
414
H65.3
ICD-10 Finland
Chronic mucoid otitis media
8.9
9.7
20
24
1290
FHL
Epipharyngoscopy
+∞
9.4
9
*
R01AD09
ATC
mometasone; nasal
2.2
9.3
133
815
QAE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in head or neck
5.8
9.0
25
47
XX3DW
NOMESCO Finland
Time consuming IT work
5.1
8.7
27
58
EP1AE
NOMESCO Finland
Neck ultrasound examination
6.0
8.7
23
41
A04AA01
ATC
ondansetron; systemic, rectal
8.3
8.5
18
23
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
+∞
8.4
8
*
YA1AD
NOMESCO Finland
CT examination of head and neck for dose design of radiotherapy
+∞
8.4
8
*
115
Kela drug reimbursment
Breast cancer
+∞
8.4
8
*
C83.31
ICD-10 Finland
Diffuse lymphoma with large B cells
+∞
8.4
8
*
L03AA13
ATC
pegfilgrastim; parenteral
+∞
8.4
8
*
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
2.1
8.4
145
951
WX404
NOMESCO Finland
Intravenous generell anesthesy
2.6
8.2
63
279
Z51.5
ICD-10 Finland
Palliative care
9.4
8.2
16
18
WX105
NOMESCO Finland
Surface analgesia on skin or mucosa
3.4
8.1
40
132
TDA90
NOMESCO Finland
Removal wax from ear
15.6
7.8
12
8
EN1BD
NOMESCO Finland
Very extensive CT examination of mouth and soft tissues of neck
15.6
7.8
12
8
TPH04
NOMESCO Finland
Cathetrisation of vein
2.5
7.7
67
316
H66.0
ICD-10 Finland
Acute suppurative otitis media
4.4
7.6
27
67
ENB00
NOMESCO Finland
Excision or exploration of lesion of pharynx
82.3
7.5
8
*
EP1CG
NOMESCO Finland
Extensive MRI examination of soft tissue of neck with high intesity magnet
82.3
7.5
8
*
R04.0
ICD-10 Finland
Epistaxis
3.8
7.4
30
85
C64.88
ICD-10 Finland
Other malignant neoplasm of kidney, except renal pelvis
+∞
7.3
7
*
C50.41
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor
+∞
7.3
7
*
Z01.1
ICD-10 Finland
Examination of ears and hearing
2.7
7.0
50
211
TDW99
NOMESCO Finland
Other minor procedure in surgery of ear, nose and larynx
7.0
6.9
16
24
GD1AD
NOMESCO Finland
Thorax CT examination
5.9
6.9
18
32
H65.0
ICD-10 Finland
Acute serous otitis media
11.3
6.9
12
11
R01BA52
ATC
pseudoephedrine, combinations; oral
2.1
6.7
88
501
J39.2
ICD-10 Finland
Other diseases of pharynx
12.7
6.6
11
9
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.0
6.6
122
794
EMB10
NOMESCO Finland
Tonsillectomy
4.9
6.6
20
43
WF003
NOMESCO Finland
Adjuvant radiotherapy
71.5
6.5
7
*
JN4BD
NOMESCO Finland
Extensive body CT
4.2
6.4
23
59
DHB10
NOMESCO Finland
Excision of lesion of internal nose
18.5
6.3
9
5
8090/3-C44.3
ICD-O-3
Basal cell carcinoma, NOS, of skin of other and unspecified parts of face
+∞
6.3
6
*
C50
ICD-10 Finland
Malignant neoplasm of breast
+∞
6.3
6
*
WF004
NOMESCO Finland
Palliative radiotherapy
+∞
6.3
6
*
C11.9
ICD-10 Finland
Malignant neoplasm: Nasopharynx, unspecified
+∞
6.3
6
*
WF049
NOMESCO Finland
Radiotherapy of metastasis
+∞
6.3
6
*
H66.9
ICD-10 Finland
Otitis media, unspecified
4.1
6.3
23
60
A04AA02
ATC
granisetron; systemic, transdermal
27.4
6.3
8
*
EP1DG
NOMESCO Finland
Very extensive examination of soft tissue of neck with high intesity magnet
27.4
6.3
8
*
R01AD08
ATC
fluticasone; nasal
2.1
6.1
84
485
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
21
31
7.19
13.75
1.1
1.2
—
—
—
0
0
195
1289
2.37
12.04
11.0
6.7
4.1
4.3
e9/l
0.41
165
1118
38
115
3.62
10.94
3.5
1.6
3.2
2.8
ug/l
0.24
31
89
68
312
2.51
9.35
3.8
2.8
0.8
0.8
mmol/l
0.55
63
286
155
1023
2.02
8.52
5.8
4.8
1.2
1.2
mmol/l
0.06
143
914
146
953
2.00
8.18
4.7
3.4
35.1
35.9
g/l
1.04
134
891
165
1131
1.97
7.97
7.2
5.2
1.2
1.2
mmol/l
0.16
138
980
71
360
2.26
7.70
2.1
1.7
—
—
—
0
0
91
513
2.09
7.54
2.5
1.9
—
—
—
0
0
189
1403
1.88
6.73
5.3
4.0
6.8
6.7
mmol/l
0.39
177
1297
148
1025
1.84
6.50
4.1
3.5
—
—
—
0
0
23
74
3.28
6.02
4.6
3.8
—
—
—
0
0
16
42
3.96
5.61
1.6
1.5
—
—
—
0
0
224
1809
1.84
5.53
10.0
5.2
80.0
75.6
u/l
0.53
209
1670
16
44
3.78
5.27
1.6
1.5
—
—
—
0
0
23
84
2.88
4.89
2.3
1.5
—
—
—
0
0
23
87
2.77
4.60
2.6
1.5
—
—
—
0
0
140
1026
1.66
4.57
2.1
1.9
97.3
96.9
pmol/l
0.03
75
521
227
1894
1.73
4.41
4.6
3.8
14.8
14.8
pmol/l
0.19
209
1728
91
600
1.73
4.38
3.5
2.8
0.2
0.4
e6/l
0.99
62
446
221
1838
1.69
4.27
5.9
4.1
13.9
11.1
mm/h
1.85
206
1695
51
284
1.95
4.22
4.1
4.5
1.0
1.0
mmol/l
0.44
46
254
93
623
1.70
4.21
3.3
2.5
323.7
9122.3
umol/l
3.54
85
548
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
17
57
3.10
4.19
2.2
2.6
0.3
0.4
u/ml
0.36
11
26
47
255
1.99
4.18
2.0
1.8
—
—
—
0
0
28
123
2.40
4.18
1.8
1.6
—
—
—
0
0
61
366
1.83
4.02
2.7
2.6
0.8
1.0
e6/l
0.28
36
210
12
33
3.74
3.96
1.7
1.4
—
—
—
0
0
42
224
2.01
3.92
1.8
1.8
312.3
364.3
nmol/l
0.79
36
200
46
256
1.93
3.81
1.9
1.8
—
—
—
0
0
104
734
1.63
3.80
3.2
2.0
2.4
2.4
mmol/l
0.00
86
615
49
280
1.89
3.75
1.7
2.3
20.7
24.4
%
1.40
42
248
16
56
2.96
3.68
1.3
1.3
—
—
—
0
0
10
26
3.94
3.55
1.7
1.3
—
—
—
0
0
11
31
3.64
3.51
1.1
1.5
0.4
0.5
nmol/l
0.45
11
26
111
810
1.57
3.48
4.3
2.9
—
—
—
0
0
56
343
1.77
3.43
2.9
2.8
3.4
2.6
e6/l
0.17
32
187
129
977
1.55
3.42
2.3
2.2
74.6
76.1
nmol/l
0.24
114
868
11
33
3.42
3.22
1.6
1.4
—
—
—
0
0
10
28
3.66
3.22
1.7
1.3
—
—
—
0
0
61
396
1.67
3.03
1.6
1.5
—
—
—
0
0
76
522
1.60
3.03
1.7
1.7
1.0
1.0
mg/l
0.09
62
388
16
63
2.62
3.00
1.3
1.2
—
—
—
0
0
15
58
2.67
2.92
1.2
1.1
—
—
—
0
0
11
36
3.13
2.83
1.1
1.1
—
—
—
0
0
45
274
1.75
2.82
6.3
5.4
103.9
104.4
mmol/l
0.20
45
266
128
1001
1.47
2.78
2.8
2.6
126.2
114.8
ug/l
0.21
117
923
70
481
1.59
2.77
1.7
1.7
1076.0
1200.1
nmol/l
0.49
51
361
250
2235
1.60
2.76
22.6
13.0
39.9
40.3
%
0.36
172
1583
80
568
1.55
2.75
2.3
2.1
2.6
3.2
mg/l
1.19
63
478
9
24
3.83
2.69
1.4
1.2
—
—
—
0
0
62
417
1.61
2.68
3.1
2.2
2.5
2.4
mmol/l
1.44
52
359
189
1602
1.46
2.64
3.7
3.0
46.3
44.5
u/l
0.10
180
1501
72
512
1.53
2.44
5.8
3.8
851.6
398.9
ng/l
0.48
56
400
99
754
1.46
2.40
2.7
2.2
58.7
56.2
u/l
0.28
90
701
51
338
1.61
2.34
31.2
20.9
1.4
1.3
inr
—
8
46
29
164
1.85
2.32
3.7
2.6
1.2
1.2
mmol/l
0.80
29
143
8
23
3.54
2.28
1.5
1.6
—
—
—
0
0
264
2422
1.59
2.27
22.1
12.1
22.1
21.4
mg/l
0.12
232
1839
98
753
1.44
2.25
2.9
3.0
1230.5
1268.8
ng/l
0.04
88
640
5
9
5.62
2.22
1.6
1.0
—
—
—
0
0
8
24
3.39
2.19
1.0
1.1
—
—
—
0
0
32
192
1.74
2.13
3.1
2.1
79.4
64.7
ml/min/173m2
—
10
78
60
425
1.51
2.06
1.3
1.3
38.7
31.7
iu/ml
0.17
21
142
39
251
1.63
2.02
9.2
6.2
1.3
1.6
mmol/l
0.20
30
197
32
199
1.68
1.89
2.5
2.6
4.6
4.4
kpa
0.18
32
191
15
73
2.11
1.84
1.3
1.1
—
—
—
0
0
8
29
2.80
1.80
1.5
1.5
—
—
—
0
0
20
110
1.87
1.77
4.6
3.4
25.2
25.0
mmol/l
0.16
20
102
10
41
2.49
1.77
1.4
1.4
—
—
—
0
0
31
195
1.65
1.77
7.3
5.6
1.8
1.3
mmol/l
0.87
31
187
103
829
1.36
1.75
4.9
3.9
15.2
8.9
mg/mmol
0.36
68
528
47
328
1.51
1.74
5.0
4.9
30.4
31.8
%
0.45
31
212
17
89
1.96
1.73
2.1
2.1
153.4
835.5
ug/l
0.72
17
80
5
14
3.61
1.62
1.2
1.3
—
—
—
0
0
5
14
3.61
1.62
1.6
4.1
—
—
—
0
0
23
137
1.73
1.60
1.7
1.5
—
—
—
0
0
7
26
2.73
1.59
1.6
1.3
—
—
—
0
0
7
26
2.73
1.59
1.7
1.3
—
—
—
0
0
11
50
2.24
1.59
2.1
1.4
—
—
—
0
0
5
15
3.37
1.53
2.0
1.1
—
—
—
0
0
5
15
3.37
1.53
2.0
1.1
—
—
—
0
0
5
15
3.37
1.53
2.0
1.1
—
—
—
0
0
28
179
1.62
1.52
2.4
3.8
74.2
84.4
ng/l
0.46
23
158
6
21
2.89
1.51
1.2
1.0
—
—
—
0
0
10
45
2.26
1.48
1.4
1.3
—
—
—
0
0
14
73
1.96
1.46
1.4
1.1
—
—
—
0
0
5
16
3.16
1.44
1.8
1.4
—
—
—
0
0
6
22
2.76
1.44
1.7
1.4
—
—
—
0
0
115
965
1.30
1.43
4.3
3.6
27.3
76.7
ng/l
0.78
86
684
6
23
2.64
1.37
2.5
3.7
—
—
—
0
0
21
128
1.69
1.37
2.0
2.3
1.5
1.3
%
0.30
21
128
261
2453
1.39
1.35
5.3
4.6
6.1
6.0
mmol/l
0.89
236
2230
169
1505
1.27
1.28
3.6
2.9
—
—
—
0
0
245
2287
1.33
1.27
6.1
4.6
1.9
2.5
mu/l
0.58
228
2097
11
56
2.00
1.23
1.0
1.2
—
—
—
0
0
8
37
2.19
1.22
1.9
1.4
—
—
—
0
0
54
415
1.36
1.22
1.4
1.3
37.6
10.9
u/ml
0.64
12
168
5
19
2.66
1.22
3.6
1.8
—
—
—
0
0
6
26
2.33
1.19
1.2
1.0
—
—
—
0
0
0
34
0.00
1.16
0.0
1.5
—
—
—
0
0
25
167
1.54
1.16
5.2
3.0
5.2
5.2
kpa
0.01
25
154
72
584
1.30
1.14
1.6
1.5
20.2
21.4
nmol/l
0.31
59
498
15
88
1.74
1.13
1.5
1.3
—
—
—
0
0
275
2626
1.40
1.11
24.7
13.9
78.9
77.9
umol/l
0.26
275
2626
65
522
1.31
1.10
1.7
1.7
128571919.0
11468324.5
pmol/l
0.43
49
436
23
153
1.54
1.10
1.3
1.5
—
—
—
0
0
81
676
1.27
1.03
1.7
1.7
1.5
1.4
mmol/l
0.27
60
568
18
115
1.60
1.02
1.3
1.3
—
—
—
0
0
245
2311
1.28
1.01
20.4
10.8
79.6
80.1
ml/min/173m2
0.15
216
1867
5
23
2.19
0.98
2.2
1.3
—
—
—
0
0
59
477
1.29
0.96
3.2
2.6
0.8
0.8
ug/l
0.02
39
300
0
32
0.00
0.95
0.0
1.5
—
—
—
0
0
248
2348
1.27
0.95
7.4
6.0
41.0
40.0
mmol/mol
0.84
230
2187
13
78
1.70
0.93
2.5
2.3
82.9
57.4
ug/min
—
8
46
6
29
2.09
0.90
1.2
1.4
—
—
—
0
0
130
1161
1.21
0.86
6.5
5.0
0.0
0.0
estimate
0.00
17
200
40
312
1.32
0.85
11.6
6.5
—
—
—
0
0
132
1183
1.20
0.84
5.2
3.6
0.0
0.0
estimate
0.00
14
195
251
2398
1.24
0.77
4.5
4.1
1.3
1.3
mmol/l
0.42
221
2200
265
2549
1.26
0.75
5.6
5.1
2.6
2.7
mmol/l
1.12
238
2356
274
2646
1.29
0.74
14.7
8.8
24.6
26.1
u/l
1.08
262
2540
266
2561
1.26
0.73
25.6
14.3
4.0
4.0
mmol/l
0.30
260
2488
10
60
1.69
0.73
2.6
1.3
—
1.1
—
0
7
12
76
1.60
0.72
1.3
1.7
43.2
40.0
nmol/l
0.13
12
71
12
76
1.60
0.72
2.0
1.6
—
—
—
0
0
62
524
1.23
0.71
1.4
1.3
0.9
1.8
u/ml
1.17
11
134
5
26
1.94
0.71
1.4
1.2
—
—
—
0
0
128
1159
1.18
0.70
5.0
3.6
0.0
0.0
estimate
0.00
17
202
89
782
1.19
0.69
2.2
2.2
147.7
267.4
u/l
0.67
84
728
11
69
1.62
0.69
1.1
1.1
—
20.9
—
0
9
29
224
1.32
0.67
4.2
3.1
—
—
—
0
0
6
36
1.68
0.57
1.2
1.1
—
—
—
0
0
6
39
1.55
0.53
1.5
1.3
67.7
60.3
pmol/l
—
6
39
12
84
1.45
0.50
1.2
1.9
—
—
—
0
0
21
163
1.31
0.49
1.1
1.2
31.7
110.3
iu/ml
—
7
70
10
69
1.46
0.45
1.1
1.1
—
11.0
—
0
10
29
241
1.22
0.42
2.4
2.5
6.9
6.6
ug/l
0.05
29
209
255
2480
1.15
0.41
5.1
4.6
1.4
1.5
mmol/l
0.79
229
2289
94
867
1.12
0.38
5.3
3.7
3.9
1.9
ug/l
0.85
81
772
19
234
0.80
0.37
2.4
2.1
—
—
—
0
0
75
684
1.13
0.37
4.2
3.6
23.3
24.2
%
0.25
40
303
6
41
1.47
0.36
1.5
1.4
—
—
—
0
0
6
41
1.47
0.36
1.5
1.4
—
—
—
0
0
6
41
1.47
0.36
1.5
1.4
—
—
—
0
0
256
2498
1.14
0.35
5.1
4.6
4.5
4.6
mmol/l
0.81
230
2316
6
43
1.40
0.35
1.7
1.7
—
—
—
0
0
10
74
1.36
0.32
1.9
1.7
—
—
—
0
0
10
77
1.31
0.26
1.5
1.3
—
—
—
0
0
34
302
1.14
0.26
1.2
1.4
—
—
—
0
0
18
210
0.85
0.23
2.2
1.9
—
—
—
0
0
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
6
49
1.23
0.20
1.3
1.7
—
—
—
0
0
7
58
1.21
0.18
1.0
1.1
—
—
—
0
0
5
63
0.79
0.08
1.0
1.4
—
—
—
0
0
91
928
0.97
0.05
5.3
3.7
—
—
—
0
0
10
90
1.11
0.05
2.8
1.9
—
—
—
0
0
11
119
0.92
0.04
1.1
1.0
—
—
—
0
0
23
220
1.05
0.03
2.0
1.8
—
—
—
0
0
61
620
0.98
0.02
6.0
3.9
0.0
0.0
estimate
0.00
17
198
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
0
7
0.00
0.00
0.0
2.7
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
0.00
0.0
2.7
—
—
—
0
0
0
6
0.00
0.00
0.0
2.3
—
1.3
—
0
6
7
72
0.97
0.00
1.6
1.5
—
—
—
0
0
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
7
73
0.96
0.00
3.1
1.9
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: CD2_BENIGN_NASOPHARYNX_EXALLC – Benign neoplasm: Nasopharynx
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).